Gleevec and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gleevec (imatinib mesylate) and Pulmicort (budesonide). Common drug interactions include overdose among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Gleevec and Pulmicort. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.



On Jul, 27, 2026

21 people who take Gleevec and Pulmicort together, and have interactions are studied.

Gleevec and Pulmicort drug interactions.

What are the common drug interactions of Gleevec and Pulmicort, by gender? *:

female:

  1. Overdose
  2. Pain
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Platelet count decreased
  5. Pneumonia
  6. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  7. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Scleral disorder (disease of sclera)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

male:

  1. Arthralgia (joint pain)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Memory impairment
  4. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  5. Spinal fracture (fracture in one of vertebrae)
  6. Vision blurred
  7. Haemoglobin decreased
  8. Knee arthroplasty
  9. Vomiting
  10. Atrioventricular block second degree (heart block second degree)

What are the common drug interactions of Gleevec and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Anaemia (lack of blood)
  4. Bacterascites (bacterial infection of ascetic fluid)
  5. Blood pressure decreased
  6. Cardiac murmur (an heart sound in valve abnormality)
  7. Depression
  8. Dyspnoea (difficult or laboured respiration)
  9. Eating disorder
  10. Fatigue (feeling of tiredness)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dry mouth
  2. Hip arthroplasty
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Accidental death
  5. Blood creatine phosphokinase increased
  6. Chest pain
  7. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  8. Confusional state
  9. Hot flush (sudden feelings of heat)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Chest discomfort
  3. Constipation
  4. Delirium (wild excitement)
  5. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  6. Duodenitis (inflammation of the duodenum)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Gait disturbance
  9. Gastritis (inflammation of stomach)
  10. Glaucoma (increased fluid pressure in the eye with vision loss)

What are the existing conditions these people have? *

  1. Pain: 8 people, 38.10%
  2. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 28.57%
  3. Stress And Anxiety: 4 people, 19.05%
  4. Indigestion: 4 people, 19.05%
  5. Hypersensitivity: 4 people, 19.05%
  6. Dyspnea (difficult or laboured breathing): 4 people, 19.05%
  7. Depression: 4 people, 19.05%
  8. Nausea And Vomiting: 2 people, 9.52%
  9. Nausea (feeling of having an urge to vomit): 2 people, 9.52%
  10. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Gleevec and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gleevec and Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gleevec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on imatinib mesylate and budesonide (the active ingredients of Gleevec and Pulmicort, respectively), and Gleevec and Pulmicort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: